Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Stacpoole

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Aging Cell|February 11, 2012
The pyruvate dehydrogenase complex as a therapeutic target for age-related diseasesPeter W Stacpoole
Environmental Health Perspectives|October 6, 2010
The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?Peter W Stacpoole
Mitochondrion|May 25, 2011
Why are there no proven therapies for genetic mitochondrial diseases?Peter W Stacpoole
Biochemical Pharmacology|September 24, 2023
Clinical physiology and pharmacology of GSTZ1/MAAIPeter W Stacpoole
Journal of the National Cancer Institute|October 24, 2017
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in CancerPeter W Stacpoole
Biochimica Et Biophysica Acta|August 27, 2014
Dichloroacetate and cancer: new home for an orphan drug?Shyam Kankotia, Peter W Stacpoole
Molecular Genetics and Metabolism|July 27, 2024
The pyruvate dehydrogenase complex at the epigenetic crossroads of acetylation and lactylationPeter W Stacpoole, Carolyn O Dirain
Pharmacogenomics|May 5, 2016
Pharmacogenetic considerations with dichloroacetate dosingMargaret O James, Peter W Stacpoole
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 18, 2014
Sleep disorders associated with primary mitochondrial diseasesRyan J Ramezani, Peter W Stacpoole
Mitochondrion|March 2, 2023
The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostatPeter W Stacpoole, Charles E McCall
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Aging Cell|February 11, 2012
The pyruvate dehydrogenase complex as a therapeutic target for age-related diseasesPeter W Stacpoole
Environmental Health Perspectives|October 6, 2010
The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?Peter W Stacpoole
Mitochondrion|May 25, 2011
Why are there no proven therapies for genetic mitochondrial diseases?Peter W Stacpoole
Biochemical Pharmacology|September 24, 2023
Clinical physiology and pharmacology of GSTZ1/MAAIPeter W Stacpoole
Journal of the National Cancer Institute|October 24, 2017
Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in CancerPeter W Stacpoole
Biochimica Et Biophysica Acta|August 27, 2014
Dichloroacetate and cancer: new home for an orphan drug?Shyam Kankotia, Peter W Stacpoole
Molecular Genetics and Metabolism|July 27, 2024
The pyruvate dehydrogenase complex at the epigenetic crossroads of acetylation and lactylationPeter W Stacpoole, Carolyn O Dirain
Pharmacogenomics|May 5, 2016
Pharmacogenetic considerations with dichloroacetate dosingMargaret O James, Peter W Stacpoole
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 18, 2014
Sleep disorders associated with primary mitochondrial diseasesRyan J Ramezani, Peter W Stacpoole
Mitochondrion|March 2, 2023
The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostatPeter W Stacpoole, Charles E McCall
Pageof 11